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Abstract
Cervical carcinogenesis is characterized by a clonal selection process in which the high-risk human papillomavirus
(HRHPV) genome usually changes from the extra-chromosomal (episomal) state seen in productive infections to
DNA that is integrated into host chromosomes. However, it is not clear whether all HRHPV integration events
provide cells with a selective growth advantage compared with the episome-containing cells from which they
originate. It is also unclear whether selection of cells containing a particular integrant from a mixed population
simply reflects the highest levels of virus oncogene expression or has additional determinants. These early events in
cervical carcinogenesis cannot readily be addressed by cross-sectional studies of clinical samples. We used the W12
model system to generate a panel of cervical squamous cell clones that were derived from an identical background
under non-competitive conditions and differed only by the genomic site of HPV16 integration. Compared with the
‘baseline’ episome-containing cells from which they were isolated, only 9/17 clones (53%) showed significantly
greater growth rates and only 7/17 (41%) showed significantly greater expression of the major virus oncogenes
E7/E6. There were significant variations in levels of HPV16 transcription per DNA template, changes that were
associated with histone modifications in the integrated virus chromatin. Cell growth rates showed only weak and
non-significant associations with protein and mRNA levels for E7, E6, and the mean E7/E6 values. We conclude
that HPV16 integration in basal cervical cells does not necessarily lead to increased levels of virus oncogenes, or
to a competitive growth advantage, when compared with the initiating episome-containing cells.
© 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain
and Ireland.
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Introduction
There are∼500 000 new cases of cervical carcinoma per
annum worldwide [1]. The large majority are squamous
cell carcinomas (SCCs), which arise from precursor
squamous intraepithelial lesions (SILs) through a
clonal selection process, characterized by the emer-
gence of cells with the greatest competitive growth
advantage [2–4]. Whereas low-grade SILs (LSILs)
represent non-neoplastic productive virus infections [5],
high-grade SILs (HSILs) are abortive infections charac-
terized by clonal expansion of morphologically atypical
cells showing elevated levels of virus oncoproteins
[6–8].
Infection with high-risk human papillomavirus
(HRHPV) is a necessary cause of cervical carcinoma
[9,10]. Whereas in productive lesions the virus DNA
is maintained in the extra-chromosomal (episomal)
state, at ∼100 copies per cell [11,12], in ∼85% of SCCs
HRHPV DNA is integrated into the host chromosomes
[2,4]. The integrant-containing carcinoma cells show
increased expression of the HRHPV oncogenes E6
and E7 [13,14], typically associated with silencing of
the virus transcriptional regulator E2 through deletion,
truncation or epigenetic silencing [14–16]. In addition,
selection of cells containing integrated HRHPV DNA
requires loss of residual virus episomes, which produce
E2 capable of repressing integrated virus DNA in trans
[4,17,18]. In in vitro models of cervical squamous car-
cinogenesis, the integrant-containing cells that emerge
from mixed populations of episome-containing cells
have a selective growth advantage [3,18].
An alternative route of cervical carcinogenesis is
characterized by episome retention and shows sim-
ilarities to integrant-associated progression [19]. In
particular, there is selection of cells with deregulation
of episome-derived transcription (compared with the
episome-containing cells of productive virus infec-
tions), leading to elevated virus oncogene expression
levels and a competitive growth advantage [19].
Several important questions concerning the biology of
HRHPV integration and cervical carcinogenesis remain
poorly addressed. First, do all integration events (when
© 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited.
282 CG Scarpini et al
derepressed following episome loss) lead to increased
levels of virus oncogenes and/or a selective growth
advantage, compared with the episome-containing cells
from which they originated? Second, does selection
of a particular integrant simply reflect the greatest
levels of virus oncogene expression per cell, or are
there additional determinants? These questions cannot
be answered by cross-sectional analysis of cervical
neoplasms, which by definition contain integrants with
the greatest competitive advantage. Moreover, clinical
samples do not allow longitudinal investigations of
events preceding integrant selection and may be con-
founded by the effects of epithelial differentiation on the
HRHPV life cycle and gene expression. Of the available
experimental systems for longitudinal studies of early
events in cervical carcinogenesis, the most useful to
date has been the W12 model [17,20,21].
Parental W12 cells represent a polyclonal population
of cervical keratinocytes (squamous epithelial cells)
generated following primary culture of a productive
lesion (cervical LSIL) that arose following natural
infection with HPV16, the most common HRHPV type
in cervical SCC. At early passages of W12, HPV16
is able to persist stably at ∼100–200 episomal copies
per cell [11]. We have used continuous in vitro passage
to generate multiple long-term culture series of W12
cells [19,22]. In these, there is usually breakdown
of episome persistence, associated with the emer-
gence of cells containing integrated HPV16. These
events are associated with chromosomal instability,
acquisition of genomic copy number imbalances, and
phenotypic progression from LSIL through high-grade
SIL (HSIL) to SCC. All of these in vitro changes
closely mirror cervical neoplastic progression in vivo
[19,22].
We have previously used theW12 model to character-
ize the range of integration events that occur following
naturally acquired HPV16 infection, prior to episome
loss and integrant selection [21]. For this, we used
W12 long-term culture series-2 (W12Ser2), in which
an integrant at 8q24.21 emerged after approximately 24
passages [where one passage (p) represents ∼6 cell dou-
blings] [18]. We studied populations of W12Ser2 cells
from early time-points prior to the emergence of the
8q24.21 integrant (ie p12 or p13), when only episomes
were detectable by Southern blot and the cells reformed
an LSIL in organotypic tissue culture [19,21]. We used
single cell cloning under non-competitive conditions,
in which episome-derived E2 was present (thereby
providing a repressive environment for integrants) until
after the cloning process. While several of the clones
that were isolated showed integration at 8q24.21, many
others showed integration elsewhere in the genome. In
total, we isolated 24 clones that each contained a differ-
ent HPV16 integration site [21]. Interestingly, despite
the cells being isolated in a non-competitive environ-
ment, the range of integration sites seen overlapped
closely with those observed in cervical SCC in vivo
(ie following a clonal selection process) [2,4,23,24].
This observation argued that HPV16 integrates at sites
in the human genome that are relatively accessible for
insertion of foreign DNA [25,26].
The clones isolated from W12Ser2 cells represent a
unique resource, as they were derived from an identi-
cal cellular background and differ only by the site of
HPV16 integration. In the present study, we performed
a detailed investigation of cell phenotype and virus
early gene expression levels across the clones, with
reference to (i) normal cervical keratinocytes (NCx);
(ii) the ‘initiating’ episome-containing W12Ser2 cells
from which the clones were generated, which reformed
an LSIL in organotypic tissue culture [18,21]; and (iii)
cells of the integrant clone that spontaneously emerged
during long-term culture of W12Ser2. The latter had
been cultured continuously to p31 and were referred
to as W12Ser2p31 cells. This in vitro approach has
provided insights into the mechanism of selection of
cells containing integrated HRHPV that cannot readily
be obtained using clinical samples or animal models.
Materials and methods
Cell culture and nomenclature
The W12 cell line system has been described in detail
previously [11,18,19,22]. Cells were routinely authenti-
cated by detection of HPV16 DNA and by identification
of characteristic genomic copy number imbalances
[20,22]. Long-term culture of polyclonal W12Ser2 has
been described previously [18,19,21]. By Southern blot-
ting, only episomes were detectable to p18, followed
by spontaneous episome clearance and the selection of
cells with HPV16 integrated at 8q24.21. Only integrated
HPV16 DNA was detectable from p24 [18].
The integrant-containing W12 clones were generated
under non-competitive conditions from W12Ser2 p12
or p13 cells, which reformed LSIL epithelia in organ-
otypic tissue culture [18,19,21]. At these early passages,
the W12Ser2 cells stably maintained episomes and
expressed E2 that was able to silence integrant-derived
transcription [18]. Consequently, there were no com-
petitive pressures to favour selection of any particular
integrant. For each clone, the site of integration into
the host DNA was determined from genomic DNA
using restriction site-PCR or from RNA using rapid
amplification of cDNA ends (RACE)-PCR [21,23,27].
In the present study, we used all of the clones avail-
able for in vitro characterization. These numbered 17 in
total, representing 16 of the clones described previously
[21] plus an additional clone (clone J3) with integration
at 8q24.21. None of the clones showed evidence of
residual episomes on Southern blotting. Details of
each clone, including the sites of HPV16 integration,
are given in Supplementary Table 1 and our previous
publication [21]. Importantly, the integrant-containing
cells were studied at the lowest available passage after
cloning (generally between p3 and p8), in order to
minimize any effects of genomic instability caused by
deregulated HPV16 oncogene expression [28].
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We compared our findings in the integrant-containing
clones with those in the ‘initiating’ episome-containing
W12Ser2 cells from p10 to p12, as well as the sponta-
neously selected W12Ser2 cells at p31 (W12Ser2p31).
We also used NCx/6 cells, derived from primary cul-
tures of normal uninfected ectocervical keratinocytes
obtained from a hysterectomy specimen performed for
disease unrelated to the cervix [19].
All cells were grown in monolayer culture using irra-
diated 3T3J2 fibroblast feeder cells and serum/growth
factor-containing medium, as previously described [29].
Such monolayer cultures were used to restrict cell dif-
ferentiation and maintain the phenotype of the basal
epithelial cell layer, the key site of HRHPV transcrip-
tional deregulation in cervical carcinogenesis [4,30].
All feeder cells were removed before the keratinocytes
were harvested. Cell doubling times and phenotype in
organotypic tissue culture were determined as previ-
ously described [22,29]. Further details are given in the
Supplementary materials and methods.
Quantification of HPV16 gene copy number,
transcript levels, and protein abundance
Copy numbers of the HPV16 early genes E7, E6, and E2
were determined using SYBRGreen (Sigma-Aldrich, St
Louis, MO, USA) quantitative PCR (qPCR) of genomic
DNA, as described elsewhere [17] (Supplementary
Table 2). Transcript levels per cell of the HPV16
early genes E7, E6, and E2 were determined using
SYBR Green quantitative reverse transcription-PCR
(qRT-PCR) (Supplementary Table 3). In this, the E7
Figure 1. Cell growth in monolayer culture and phenotype in organotypic tissue culture. (A) Population doublings per day in W12 clones
(blue bars), the spontaneously selected W12Ser2p31 cells (pale blue bar), the initiating episome-containing W12Ser2p10 and W12Ser2p12
cells (purple bars), and NCx/6 (grey bar). Error bars = SEM. An asterisk denotes cells with significantly faster growth than the mean of
the W12Ser2p10 and W12Ser2p12 cells (p < 0.01). (B, C) Appearances of the epithelia reformed in organotypic culture by representative
W12 clones, for which growth rate in monolayer culture was low (Q and J) or high (H2 and B). Tissue sections were stained by H&E and
immunohistochemistry for the cell-cycle marker MCM2 and the squamous cell differentiation markers KRT10/13. Scale bars= 50 μm.
© 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2014; 233: 281–293
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Figure 2. Quantification of virus gene expression and copy number. The charts show levels of expression (left column) and copy number
(right column) for HPV16 E7 (panels A, E), total E6 (panels B, F), and E2-5’/E2-3’ (panels D, H). Expression levels were referenced to those
in W12Ser6p11. Relationships between the E7 and E6 levels are shown in panels C and G, including correlation data for the 17 clones. The
pale blue bars/circles show data for the spontaneously selected W12Ser2p31 cells, while the purple bars/circles show data for the initiating
episome-containing W12Ser2p10 and W12Ser2p12 cells. Data for the 17 clones are colour-coded by gene (E7: blue bars; E6: red bars; E2:
orange bars). In each bar chart, the clones are ordered by increasing levels of E7 transcript per cell (ie the order determined in the analysis
shown in panel A). Rel= relative. Error bars = SEM. An asterisk denotes cells where E7 or E6 values were significantly higher than the mean
of the W12Ser2p10 and W12Ser2p12 cells (p < 0.01).
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primers detected all transcripts encoding the E7 protein.
We used a range of primer pairs to quantify total E6
transcripts, as well as the alternatively spliced forms,
E6*I, E6*II, E6*III, E6*IV, E6*X, and full length E6
[31]. Separate primer pairs were used to quantify the
5′ and 3′ ends of E2 [32]. In addition, we combined
the HPV16 expression and gene copy number quan-
tification data to determine the levels of transcription
per DNA template copy for E7, E6, and E2, as previ-
ously described [19]. Levels of HPV16 proteins were
measured using quantitative western immunoblotting,
as previously described [17,19]. Full details of qPCR
and quantitative immunoblotting may be found in the
Supplementary materials and methods.
Chromatin immunoprecipitation (ChIP)
ChIP analysis of histone modifications was performed
as previously described [19]. PCR quantification of
HPV16 DNA sequences in the immunoprecipitated
chromatin covered six sites along the HPV16 genome,
from the long control region to the E1 open reading
frame (Supplementary Table 4). Further details are
given in the Supplementary materials and methods.
Results
Cell growth and epithelial morphology
Across the 17W12 clones available for analysis, the
number of population doublings per day in monolayer
culture varied by ∼1.5-fold (Figure 1A), equating to
an ∼17-fold difference in the number of population
doublings if extended over 1 week. Predictably, the
cells that had been spontaneously selected during
long-term culture of W12Ser2 (W12Ser2p31) had one
of the highest population doubling rates, with none
of the clones showing a significantly greater rate. The
number of population doublings per day of the initiating
episome-containing W12Ser2 cells was ∼75% of that of
the W12Ser2p31 cells and not significantly greater than
that of NCx/6 cells (Figure 1A). Interestingly, only 9/17
clones (53%) showed a significantly greater population
doubling rate than the initiating episome-containing
W12Ser2 cells (p< 0.01).
We used three-dimensional organotypic tissue culture
to test whether the differences in cell growth rates
across the clones in monolayer culture were reflected in
differences in the morphology of the epithelia reformed
Figure 3. Levels of HPV16 gene expression per template. Values are shown for E7 (A) and E6 (B), with correlations between the values for the
17 clones shown in C. The pale blue bars/circles show data for the spontaneously selected W12Ser2p31 cells, while the purple bars/circles
show data for the initiating episome-containing W12Ser2p10 and W12Ser2p12 cells. The bars for the 17 clones are colour-coded by gene
(E7: blue bars; E6: red bars). In each bar chart, the clones are ordered by increasing levels of E7 expression per template (ie the order
determined in the analysis shown in panel A). Error bars = SEM. An asterisk denotes cells where values were significantly higher than the
W12Ser2p31 cells (p < 0.01). Panel D shows a plot of mean E6/E7 expression per template versus template copy number per cell. While
individual W12 clones are generally represented by black circles, specific colours are used to highlight the clones used for ChIP–qPCR.
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by the cells in vitro. For two representative clones (Q
and J) (Figure 1B) in which cell growth was no greater
than that of the initiating episome-containing cells, only
the basal ∼1/3 of the reformed epithelium contained
morphologically atypical cells that were in cell cycle (as
evidenced by expression of MCM2). Cells in the upper
∼2/3 of the epithelium showed evidence of differentia-
tion on H&E staining, associated with expression of the
squamous epithelial differentiation markers KRT10/13.
Together, these histological changes resembled LSIL.
In contrast, for two representative clones (H2 and B)
(Figure 1C) in which cell growth was significantly
greater than that of the initiating episome-containing
cells (p< 0.01), atypical cycling cells extended into
the upper ∼1/3 of the epithelium. This was associated
with little evidence of differentiation on H&E staining,
and with an almost complete absence of KRT10/13
expression, save for occasional individual dyskeratotic
cells. Together, these changes were of higher grade than
the epithelia reformed by clones Q and J and resembled
HSIL. None of the clones examined showed evidence
of invasion in organotypic tissue culture. We concluded
that comparative measurements of cell growth in mono-
layer culture were valid indicators of cell phenotype
(proliferation and differentiation) in stratified epithelia.
HPV16 transcript levels per cell
Across the 17 clones, levels per cell of HPV16 E7
transcripts varied by ∼6-fold (Figure 2A) and levels
of HPV16 total E6 transcripts by ∼5-fold (Figure 2B).
When compared with the initiating episome-containing
W12Ser2 cells, only 7/17 (41%) showed signifi-
cantly higher levels of E7 (p< 0.01) and only 7/17
(41%) clones showed significantly higher levels of
E6 (p< 0.01). Interestingly, in W12Ser2p31 cells,
which grew rapidly in monolayer culture and were
spontaneously selected from the polyclonal W12Ser2
cultures [18], levels of E7 and E6 were relatively mod-
erate (Figures 2A and 2B), with two clones (R2 and
J3) showing significantly higher levels of E7 and E6
(p< 0.01). Across the 17 clones, there was a highly
significant correlation between the levels of E7 and
total E6 transcripts per cell (p< 0.0001) (Figure 2C). In
addition, levels of E7 and total E6 correlated with levels
of the alternative E6 transcripts E6*I, E6*II, and E6*X,
as well as E6 full length (Supplementary Figure 1).
We quantified levels of the 5′ and 3′ ends of the E2
transcript separately, given our previous finding that the
E2 gene is typically disrupted in the integrant-containing
clones [4,21], reflecting a common feature of the
HRHPV integrants seen in cervical SCC in vivo [14,16].
Of the 17 clones, five (29%) showed loss of all E2
transcripts, while only one (S2) showed substantial
levels of E2-3′ transcripts (Figure 2D). Eleven clones
expressed E2-5′ transcripts, with the levels varying by
∼44-fold. There was no overall correlation between
levels of E2-5′ transcripts and those of E7, total E6
or any alternative E6 transcript (data not shown). The
selected W12Ser2p31 cells expressed both E2-5’and
E2-3′, similar to clone S2.
Relationship between HPV16 transcript levels
and gene copy number
We tested whether the wide range in gene expression
levels could be explained by differences in HPV16
DNA template abundance. We used qPCR to quantify
gene copy number for HPV16 E7, E6, E2-5′, and E2-3′
(Supplementary Table 2). The E7 and E6 copy numbers
ranged from ∼1 to 14 and from ∼1 to 16, respectively
(Figures 2E and 2F), with a highly significant corre-
lation between the values (p< 0.0001) (Figure 2G).
With the exception of four clones (E3, Q2, S2, and
H2), copy numbers of E2-5′ and/or E2-3′ were 1 or 0
(Figure 2H) (Supplementary Figure 2). This supported
previous Southern blot evidence [21] and indicated the
absence of full-length virus concatemerization (ie the
clones harboured so-called type I integrants) [13]. Some
of these clones nevertheless contained multiple copies
of E6/E7, consistent with effects of local DNA rear-
rangements following integration [33–35]. Across all
the clones, there was no correlation between transcript
levels and gene copy number for E7, total E6 or E2-5’
(Supplementary Figures 3A–3C).
The range of transcript levels per template varied
for both E7 and total E6 by ∼16-fold and ∼17-fold,
respectively (Figures 3A and 3B). Interestingly, expres-
sion levels per template for the spontaneously selected
W12Ser2p31 cells were relatively moderate, with 2/17
(12%) clones (A5 and F) showing significantly greater
levels of E7 and E6 expression per template (p< 0.01).
Across all clones, there was a highly significant cor-
relation between levels of E6 and E7 expression per
template (p< 0.0001) (Figure 3C). Transcript levels
per template for E2-5′ (where expressed) varied by
∼13-fold (Supplementary Figure 4), with no correlation
with transcript levels per template for E7, total E6 or
E2-3′ (data not shown).
Given the close correlation between levels of E6 and
E7 expression per template, the values were combined
to produce a mean level of E6/E7 mRNA expression per
template. When this parameter was plotted against mean
E6/E7 DNA copy number, we observed an overall neg-
ative relationship, with high DNA copy number clones
showing relatively low levels of expression per template
and vice versa (Figure 3D). However, there were mul-
tiple examples where clones that contained the same or
very similar DNA copy number (with no evidence of
full-length virus concatemerization) showed significant
differences in levels of E6/E7 expression per template.
For example, of the clones with three or four E6/E7
copies per cell, clone D2 showed ∼3.7-fold greater
expression per template than clone G2 (p= 0.036),
while of the clones with one copy per cell, clone F
showed ∼3.3-fold greater expression per template than
clone H (p= 0.007).
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Figure 4. Histone modifications in integrated HPV16 chromatin. In each graph, the y-axis shows fold enrichment of histone H3
modifications, referenced to background H3 levels. The x-axis and underlying schematic show the region of the HPV16 genome analysed by
qPCR (LCR = long control region). Histone modifications of active chromatin are shown in panel A and modifications of repressed chromatin
in panel B. The columns show data for clones in which transcription levels per template were high (left), medium (MED; middle) or low
(right).
© 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2014; 233: 281–293
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Relationship between transcript levels per template
and virus chromatin modifications
We hypothesized that the significant variations in E6/E7
expression per template were due to epigenetic differ-
ences in the virus chromatin related to transcriptional
control. We therefore used ChIP–qPCR to measure
levels of histone modifications associated with tran-
scriptionally active or repressed DNA templates. To
avoid any complexity caused by heterogeneous changes
in cells containing concatemerized integrants, we
focused on clones where E6/E7 copy number was 4
or less and there was no retention (or expression) of
either E2-5′ or E2-3′. From this group, we selected
two clones with high levels of expression per template
(F and A5), two with medium levels (D2 and H), and
the one available clone with low levels (G2). Across
these clones, increasing levels of virus expression per
template were associated with increasing levels of his-
tone marks of transcriptionally active DNA templates
(acetylated histone H3 and trimethylated lysine 4 of
histone H3) (Figure 4A) and with decreasing levels
of histone marks of transcriptionally repressed DNA
templates (dimethylated lysine 9 of histone H3 and
dimethylated lysine 27 of histone H3) (Figure 4B).
HPV16 protein levels and cell growth rates
Across the 17 clones, levels of HPV16 E7 and E6
proteins per cell each varied ∼6-fold (Figures 5A–5C).
When compared with the initiating episome-containing
W12Ser2 cells, only 7/17 (41%) clones showed sig-
nificantly higher levels of E7 (p< 0.01), while only
1/17 (6%) showed significantly higher levels of E6
(p< 0.01). Full-length E2 protein was not detectable in
any clone (Supplementary Figure 5B), consistent with
the general absence of E2-3′ transcripts (Figure 2D).
Across the clones, there was a significant correlation
between levels of mRNA and protein for E7 (p= 0.008)
(Figure 5D), total E6 (p= 0.03) (Figure 5E), and the
mean E6/E7 values (p= 0.0001) (Figure 5F). Levels of
E6 protein did not correlate with any of the alternative
E6 transcripts individually (Supplementary Figures
6A–6 F), although E7 protein did correlate significantly
with levels of E6*I (p= 0.0005) and E6*II transcripts
(p< 0.0001) (Supplementary Figures 6H and 6I).
Cell growth rates showed only weak and non-
significant associations with protein levels of E7
(Figure 6A), E6 (Figure 6B), and the mean E6/E7 values
(Figure 6C). There was no association between E6 : E7
protein ratios and cell growth rates (Figure 6D). There
were multiple instances where cells with similar E6/E7
protein levels showed significant differences in growth
rates. This applied to clones where levels of E6/E7
proteins per cell were low (eg G2 versus A5, p= 0.023)
or higher (eg 3 versus Q, p= 0.009). These observa-
tions were mirrored by evidence of only weak and
non-significant associations between growth rate and
transcript abundance for E7 (Supplementary Figure
7A), total E6 (Supplementary Figure 7B), and the mean
E6/E7 values (Supplementary Figure 7C). Likewise,
there were only weak and non-significant correlations
between growth rates and levels of the alternative E6
transcripts, both individually (Supplementary Figures
8A–8 F) and when combined with E7 to produce mean
values (Supplementary Figures 8G–8L). There was no
association between total E6 : E7 transcript ratios and
cell growth rates (Supplementary Figure 7D).
Discussion
Basal cells derived from non-neoplastic productive
HRHPV infections typically contain ∼100 episomes per
cell [11,12]. As integration generally involves a small
proportion of these episomes, the residual episomes
must be cleared from cells in order to remove E2 that is
capable of repressing integrant-derived transcription in
trans [18]. The W12 clones studied here were derived
from W12 culture series-2 cells in which only epi-
somes were detectable by Southern blot and expression
from integrants was repressed [21]. The clones there-
fore contained naturally occurring HPV16 integration
sites, regardless of their selectability in mixed cell
populations.
This panel of clones has demonstrated that integra-
tion of HPV16 in basal cervical squamous epithelial
cells does not necessarily lead to increased levels
of virus oncogene expression, or to a competitive
growth advantage, when compared with the initiat-
ing episome-containing cells that reformed an LSIL
in organotypic tissue culture. Indeed, only 53% of
the integrant-containing clones had a growth advantage
compared with the episome-containing cells fromwhich
they were derived. This finding strongly supports our
experimental strategy of using single cell cloning under
non-competitive conditions to isolate cells containing
individual HPV16 integrants [21], as the eight clones
without a relative growth advantage would not have
outgrown the parental episome-containing cells and
would not have emerged from the mixed cell population
while episome-containing cells remained. We consider
that the differences in growth rates observed in mono-
layer culture were valid indications of cell phenotype,
as they correlated with the morphology of the epithelia
reformed by the clones in organotypic tissue culture.
This finding is consistent with previous observations in
studies of episome-associated cervical carcinogenesis,
where increased cell growth rates (associated with
deregulated episome-derived transcription) were mir-
rored by phenotypic progression in organotypic tissue
culture, from LSIL through HSIL to SCC [19,36].
We deliberately studied the W12 clones at the earliest
available passage, in order to minimize any confounding
effects of genomic instability caused by deregulated
HPV16 gene expression [28]. It is difficult to investi-
gate early events in cervical neoplastic progression by
cross-sectional analysis of clinical samples. Carcinoma
tissues are not suitable, as progression to malignancy
is associated with cell selection, dynamic changes in
HRHPV gene expression (whether the cells contain
© 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2014; 233: 281–293
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Figure 5. Expression levels of HPV16 early proteins per cell. Panel A shows western blots for HPV16 E6 and E7 protein expression in
representative W12 clones. The reference samples were from independent episome-containing W12Ser6p11 cells. The right-hand five lanes
in each blot show the serial dilution of W12 clone B used to generate the standard curve for protein quantification, with the numbers
denoting the μg amounts of total protein per lane. The bar charts show protein levels for E7 (B) and E6 (C). The pale blue bars show data
for the spontaneously selected W12Ser2p31 cells, while the purple bars show data for the initiating episome-containing W12Ser2p10 and
W12Ser2p12 cells. An asterisk denotes cells where values were significantly higher than the mean of the W12Ser2p10 and W12Ser2p12
cells (p < 0.01). Relationships between protein and transcript levels are shown for E7 (D), total E6 (E), and the mean E7/E6 values (F),
including correlation data for the 17 clones (black circles). In all panels, error bars = SEM. A.U. = arbitrary units.
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Figure 6. Relationships between cell proliferation rates and HPV16 oncoprotein levels. The graphs plot cell growth rate versus protein levels
for E7 (A), E6 (B), the mean E6/E7 values (C), and the E6 : E7 ratios (D). The correlation data are for the 17 clones (black circles). Results for
the W12Ser2p31 cells (pale blue circles) and W12Ser2p10 and W12Ser2p12 cells (purple circles) are also shown. In all panels, error bars =
SEM. A.U.; arbitary units.
integrants or episomes), and the accumulation of global
host genomic imbalances [4,6–8,19]. The available
data on HPV expression levels in SILs [37] were mostly
derived from HSILs (CIN2/3), in which clonal selection
of growth-advantaged cells would have occurred [6,7],
plus some LSILs (CIN1) that included the terminally
differentiated upper strata where E6/E7 levels increase
during the normal HPV life cycle [30,38]. In future
work, it will be interesting to determine virus expres-
sion levels in microdissected basal epithelial layers
of episome-containing productive HRHPV infections
(cervical LSILs), which would provide an appropriate
reference for studies of integrant-containing cells. In the
meantime, in order to establish definitively the effects
of HRHPV integration on virus gene expression in the
absence of any effects of cell selection or differenti-
ation, it is necessary to compare episome-containing
and integrant-containing basal type cells in monolayer
culture, as performed in the present study.
Across the 17W12 clones studied, levels of virus gene
expression per cell did not correlate with DNA template
abundance. Indeed, expression levels per template
varied up to ∼17-fold. For all integrants, expression
levels per template were greater than in the initiating
episome-containing cells, indicating the different tran-
scriptional environment of integrated versus episomal
HPV16 genomes [4,13]. The majority of clones showed
no evidence of concatemerization of full-length virus
DNA (ie were type I integrants). By studying represen-
tative clones, we observed that variations in levels of
transcription per template were associated with epige-
netic differences in virus chromatin. High-level expres-
sion per template was associated with greater abundance
of histone marks associated with active chromatin and
reduced abundance of marks associated with repressed
chromatin [39]. Interestingly, levels of the active chro-
matin marks were greatest over the transcribed virus
exons downstream of the transcription start site, consis-
tent with observations in the HPV18 integrants found in
the cervical adenocarcinoma cell line HeLa [40]. This
epigenetic variation in integrated HPV16 DNA reflects
changes in episome-associated cervical carcinogenesis
[19], where deregulation of HPV transcription was
associated with changes in histone acetylation in viral
episomes, downstream of the transcription start sites.
In future work, it will be important to study the
causes and consequences of histone modifications in the
W12 clones and whether high-level transcription from
integrated HPV16 may be reduced using epigenetic
therapies. Where HRHPV DNA is integrated as con-
catemerized full-length copies (ie as type II integrants)
[13], the overall virus chromatin state is likely to be
heterogeneous, as transcription sites may be restricted
to the 3’ virus–host junctions [41]. However, the levels
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of transcription per DNA template at such junctions
may be related to histone modifications similar to those
identified in the present study.
The overall correlations that we observed between
virus mRNA and protein levels per cell argue against
significant post-transcriptional regulation in the
integrant-containing W12 clones. While there was
some association between growth rates and levels of
virus oncoproteins, this was weak and statistically not
significant. As the functions of HRHPV E6 and E7 are
interconnected [2,4,6–8], it is conceivable that there
may an optimal ratio of E6 : E7 levels for stimulation
of cell proliferation. However, we found no evidence of
this in our dataset. There were significant differences
between the growth rates of clones showing the same
E6/E7 protein levels, at both low and high protein levels
per cell. These data argue strongly for a host contri-
bution to the growth of HPV16 integrant-containing
basal cervical keratinocytes. It will now be important
to investigate the relative contributions of host genes
at or near the integration sites, the expression and copy
number of which may be directly affected by HPV16
integration [33–35,42], compared with genes elsewhere
in the genome, which may be deregulated indirectly, for
example through stochastically acquired copy number
imbalances and/or mutations [28]. There is evidence of
increased genomic instability in integrant-containing
cells selected in mixed cell populations [19,22]. Inter-
estingly, HPV oncogenes expressed from episomes
may also induce host genomic imbalances that could
contribute to viral integration and potentially provide a
selective growth advantage [25,26].
Finally, it should be noted that while the panel of
integrant-containing cells studied here was generated
under non-competitive conditions, regardless of their
relative growth advantage, all were isolated in mono-
layer culture and required retention of the E6 and E7
genes. It is conceivable that other HPV16 integration
events occur in vivo that disrupt E6/E7 and are therefore
ultimately non-selectable. Such integrants would not
have been isolated by the strategy that we adopted. They
may be identified by high-throughput sequencing anal-
ysis of episome-containing productive lesions (LSILs),
prior to the selection pressures induced by episome
clearance and loss of trans-repressive E2.
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